Demonstrates the negative impact of annexin A2 in gastric adenocarcinoma, suggesting its potential as a therapeutic target.
This study is the first to demonstrate the adverse prognostic impact of ANXA2 overexpression in gastric adenocarcinoma tissues from Caucasian patients. Our results suggest that ANXA2 might have utility as a prognostic biomarker and therapeutic target, if further large-scale studies validate and expand our findings.
No takes yet. Share an insight, caveat, or question.
Christofidis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: